tradingkey.logo

ImageneBio Ord Shs

IMA
6.180USD
-0.010-0.16%
Close 12/19, 16:00ETQuotes delayed by 15 min
69.10MMarket Cap
LossP/E TTM

ImageneBio Ord Shs

6.180
-0.010-0.16%

More Details of Company

ImageneBio Ord Shs Info

Ticker Symbol- -
Company name- -
IPO date- -
CEO- -
Number of employees- -
Security type- -
Fiscal year-end- -
Address- -
City- -
Stock exchange- -
Country- -
Postal code- -
Phone- -
Website- -
Ticker Symbol- -
IPO date- -
CEO- -

Company Executives of ImageneBio Ord Shs

Name
Name/Position
Position
Shareholding
Change
Ms. Erin Butler
Ms. Erin Butler
Senior Vice President - Finance, Administration
Senior Vice President - Finance, Administration
3.05K
+1101.18%
Mr. Joseph P. Slattery
Mr. Joseph P. Slattery
Director
Director
--
--
Dr. Kristin Yarema, Ph.D.
Dr. Kristin Yarema, Ph.D.
Chief Executive Officer, Interim Principal Financial Officer, Director
Chief Executive Officer, Interim Principal Financial Officer, Director
--
--
Dr. Yufang Lu, M.D., Ph.D.
Dr. Yufang Lu, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
--
--
Name
Name/Position
Position
Shareholding
Change
Ms. Erin Butler
Ms. Erin Butler
Senior Vice President - Finance, Administration
Senior Vice President - Finance, Administration
3.05K
+1101.18%
Mr. Joseph P. Slattery
Mr. Joseph P. Slattery
Director
Director
--
--
Dr. Kristin Yarema, Ph.D.
Dr. Kristin Yarema, Ph.D.
Chief Executive Officer, Interim Principal Financial Officer, Director
Chief Executive Officer, Interim Principal Financial Officer, Director
--
--
Dr. Yufang Lu, M.D., Ph.D.
Dr. Yufang Lu, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
--
--

Revenue Breakdown

FY2025Q3
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
Relevant data have not been disclosed by the company yet.
By RegionUSD
Name
Revenue
Proportion
United States
0.00
0.00%
By Business
By Region
Relevant data have not been disclosed by the company yet.

Shareholding Stats

Updated: Wed, Dec 10
Updated: Wed, Dec 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Engene Inc
9.12%
Deep Track Capital LP
8.25%
BVF Partners L.P.
7.53%
Blue Owl Capital Holdings LP
5.08%
Omega Fund Management, LLC
4.28%
Other
65.75%
Shareholders
Shareholders
Proportion
Engene Inc
9.12%
Deep Track Capital LP
8.25%
BVF Partners L.P.
7.53%
Blue Owl Capital Holdings LP
5.08%
Omega Fund Management, LLC
4.28%
Other
65.75%
Shareholder Types
Shareholders
Proportion
Hedge Fund
17.61%
Corporation
10.79%
Investment Advisor
9.94%
Venture Capital
9.01%
Investment Advisor/Hedge Fund
4.02%
Individual Investor
3.89%
Private Equity
3.55%
Research Firm
0.02%
Other
41.17%

Institutional Shareholding

Updated: Tue, Dec 9
Updated: Tue, Dec 9
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
140
4.75M
44.62%
+1.09M
2025Q3
149
4.75M
44.63%
+904.63K
2025Q2
149
2.80M
80.96%
-570.89K
2025Q1
150
2.82M
81.38%
-1.12M
2024Q4
149
3.19M
92.09%
+164.51K
2024Q3
156
2.55M
73.79%
-1.03M
2024Q2
156
3.25M
94.96%
-481.24K
2024Q1
143
3.36M
98.10%
-401.43K
2023Q4
138
3.53M
103.06%
+553.39K
2023Q3
138
2.84M
91.98%
-62.81K
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
Engene Inc
971.17K
9.12%
+971.17K
--
Sep 08, 2025
Deep Track Capital LP
878.52K
8.25%
--
--
Sep 30, 2025
BVF Partners L.P.
802.10K
7.53%
+468.22K
+140.24%
Sep 30, 2025
Blue Owl Capital Holdings LP
540.92K
5.08%
+200.00K
+58.66%
Sep 30, 2025
Omega Fund Management, LLC
455.36K
4.28%
+267.93K
+142.95%
Sep 30, 2025
OrbiMed Advisors, LLC
378.56K
3.55%
--
--
Sep 30, 2025
Atlas Venture
377.81K
3.55%
-40.37K
-9.65%
Sep 30, 2025
RTW Investments L.P.
334.44K
3.14%
+334.44K
--
Sep 30, 2025
Wang (Stephen Hui)
250.72K
2.35%
+250.72K
--
Sep 08, 2025
The Vanguard Group, Inc.
233.36K
2.19%
+115.55K
+98.09%
Sep 30, 2025
View more

Related ETFs

Updated: Tue, Dec 9
Updated: Tue, Dec 9
Name
Proportion
iShares Micro-Cap ETF
0.01%
Dimensional US Core Equity 1 ETF
0%
iShares Russell 2000 ETF
0%
Global X Russell 2000 Covered Call ETF
0%
ProShares UltraPro Russell2000
0%
ProShares Hedge Replication ETF
0%
iShares Russell 2000 Value ETF
0%
Global X Russell 2000 ETF
0%
Proshares Ultra Russell 2000
0%
iShares Micro-Cap ETF
Proportion0.01%
Dimensional US Core Equity 1 ETF
Proportion0%
iShares Russell 2000 ETF
Proportion0%
Global X Russell 2000 Covered Call ETF
Proportion0%
ProShares UltraPro Russell2000
Proportion0%
ProShares Hedge Replication ETF
Proportion0%
iShares Russell 2000 Value ETF
Proportion0%
Global X Russell 2000 ETF
Proportion0%
Proshares Ultra Russell 2000
Proportion0%

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data

Stock Split

Date
Type
Ratio
Jul 15, 2025
Merger
12→1
Date
Type
Ratio
Jul 15, 2025
Merger
12→1

FAQs

Who are the top five shareholders of ImageneBio Ord Shs?

The top five shareholders of ImageneBio Ord Shs are:
Engene Inc holds 971.17K shares, accounting for 9.12% of the total shares.
Deep Track Capital LP holds 878.52K shares, accounting for 8.25% of the total shares.
BVF Partners L.P. holds 802.10K shares, accounting for 7.53% of the total shares.
Blue Owl Capital Holdings LP holds 540.92K shares, accounting for 5.08% of the total shares.
Omega Fund Management, LLC holds 455.36K shares, accounting for 4.28% of the total shares.

What are the top three shareholder types of ImageneBio Ord Shs?

The top three shareholder types of ImageneBio Ord Shs are:
Engene Inc
Deep Track Capital LP
BVF Partners L.P.

How many institutions hold shares of ImageneBio Ord Shs (IMA)?

As of 2025Q4, 140 institutions hold shares of ImageneBio Ord Shs, with a combined market value of approximately 4.75M, accounting for 44.62% of the total shares. Compared to 2025Q3, institutional shareholding has increased by -0.01%.

What is the biggest source of revenue for ImageneBio Ord Shs?

In FY2025Q3, the -- business generated the highest revenue for ImageneBio Ord Shs, amounting to -- and accounting for --% of total revenue.
KeyAI